» Articles » PMID: 24457845

Overview of MS Spasticity

Overview
Journal Eur Neurol
Specialty Neurology
Date 2014 Jan 25
PMID 24457845
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials.

Kleiner D, Horvath I, Bunduc S, Gergo D, Lugosi K, Fehervari P Curr Neuropharmacol. 2023; 21(12):2505-2515.

PMID: 37519000 PMC: 10616923. DOI: 10.2174/1570159X21666230727094431.


Arbaclofen extended-release tablets for spasticity in multiple sclerosis: open-label extension study.

Okuda D, Kantor D, Jaros M, deVries T, Hunter S Brain Commun. 2023; 5(1):fcad026.

PMID: 36861013 PMC: 9968651. DOI: 10.1093/braincomms/fcad026.


Arbaclofen extended-release tablets for spasticity in multiple sclerosis: randomized, controlled clinical trial.

Okuda D, Kantor D, Jaros M, deVries T, Hunter S Brain Commun. 2022; 4(6):fcac300.

PMID: 36519155 PMC: 9732858. DOI: 10.1093/braincomms/fcac300.


Multiple Sclerosis Identification Based on Fractional Fourier Entropy and a Modified Jaya Algorithm.

Wang S, Cheng H, Phillips P, Zhang Y Entropy (Basel). 2020; 20(4).

PMID: 33265345 PMC: 7512770. DOI: 10.3390/e20040254.


MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial.

Hugos C, Cameron M BMC Neurol. 2020; 20(1):368.

PMID: 33028236 PMC: 7541326. DOI: 10.1186/s12883-020-01902-1.